Bladder cancer prognosis varies with invasiveness, requiring treatments like surgery or chemotherapy. Immune checkpoint inhibitors, such as Avelumab, are standard for advanced cases but can cause side effects like neutropenia and esophagitis, as seen in a reported case during Avelumab maintenance therapy.
No takes yet. Share an insight, caveat, or question.
Hirano et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: